Fundraising FoxAtreo
San Francisco, US · Founded 2021 · Delaware corporation
Find your way into Atreo
164 people in our graph share verified history with the Atreo team — schools, employers, funds. One of them is your warm intro.
CHRISTINE OLIVERunlockedknows Ryan Harrison · together at endpoint Clinical (overlapped)
×2knows the team · via endpoint Clinical
×9knows the team · via Bentley University
Atreo builds RTSM (Randomization and Trial Supply Management) software for clinical trial teams in the life sciences industry. Its platform supports study deployment across all trial phases with a focus on agility, quality, and reduced supply management costs.
Founders & leadership
Atreo was founded in 2021 by Ryan Harrison and Jon Ball.
RH
Ryan HarrisonChief Executive OfficerRyan Harrison is Chief Executive Officer of Atreo, which builds RTSM (Randomization and Trial Supply Management) software for clinical trial teams. He has experience working on RTSM systems and challenges within the life sciences industry.
Reported raises · per SEC filings
Form D private placements$3.8M disclosed across 1 round · 2022
▶$3.8MraisedJun 2022 · 28 investors · Other Health CareRule 506(b)
▶$3.8MraisedJun 2022 · 28 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ryan HarrisonExecutive Officer, Director
- Jonathan BallExecutive Officer, Director
- John RanzExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $3.8M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlap
Korio8 shared keywordsKorio provides RTSM (Randomization and Trial Supply Management) software for clinical trials, with a focus on experienced project management and continuity throughout the study lifecycle. The company serves clinical operations teams and sponsors managing treatment assignment and supply logistics in regulated pharmaceutical trials.
Veeva6 shared keywordsVeeva Clinical Platform is a cloud-based suite of connected applications for running clinical trials, covering clinical operations, clinical data, research sites, and patients. It serves biopharma sponsors, clinical research sites, and patients across trial management, data capture, and disclosures.
Reltio6 shared keywordsReltio is a cloud-native, software-as-a-service (SaaS) data platform that helps enterprises manage and unify master data to deliver business outcomes. It serves Global 2000 companies seeking to accelerate data value and power data-driven decision-making through real-time, trusted data and AI integration.
Suvoda5 shared keywordsSuvoda provides software solutions for managing complex clinical trials, including therapeutic areas such as oncology, central nervous system disorders, and rare disease. It serves pharmaceutical and clinical research customers, helping remove barriers to trial participation and expand access.
4G Clinical5 shared keywords4G Clinical builds randomization and trial supply management (RTSM) technology for complex clinical trials, serving biotech, biopharma, and CRO sponsors. Its software handles randomization, drug supply forecasting, scenario modeling, and system integrations across the study lifecycle.
Companies competing with Atreo for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Atreo do?
- Atreo builds RTSM (Randomization and Trial Supply Management) software for clinical trial teams in the life sciences industry. Its platform supports study deployment across all trial phases with a focus on agility, quality, and reduced supply management costs.
- Who founded Atreo?
- Atreo was founded by Ryan Harrison, Jon Ball in 2021.
- How much funding has Atreo raised?
- Atreo has disclosed $3.8M raised across 1 round.
- Where is Atreo headquartered?
- Atreo is headquartered in San Francisco, US.